The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells (Q28285958)

2

0 references

M F Molina

3

0 references

M Kourelis

4

0 references

S Kwan

5

0 references

Z Diaz

6

0 references

H M Schipper

7

0 references

A Gupta

8

0 references

S V del Rincon

9

0 references

K K Mann

10

0 references

W H Miller

Darinaparsin: a novel organic arsenical with promising anticancer activity

11

0 references

language of work or name

English

0 references

publication date

November 2013

0 references

published in

Leukemia

0 references

volume

27

0 references

issue

11

0 references

page(s)

2220-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Elevation of glutathione levels and glutathione S-transferase activity in arsenic-resistant Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Glutathione plays different roles in the induction of the cytotoxic effects of inorganic and organic arsenic compounds in cultured BALB/c 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Mechanisms of cell protection by heme oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

BACH1 is a specific repressor of HMOX1 that is inactivated by arsenite

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Mitotic inactivation of a human SWI/SNF chromatin remodeling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

A quantitative atlas of mitotic phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

A phase I clinical trial of darinaparsin in patients with refractory solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Early-stage apoptosis is associated with DNA-damage-independent ATM phosphorylation and chromatin decondensation in NIH3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Biological responses to arsenic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

Biliverdin reductase: a major physiologic cytoprotectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54

ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.54